WORX Rasio silihan jangka dawa marang modal scworx.com

Tandha merek SCWorx Inc (WORX)

SCWorx Corp. (WORX) faces profit vulnerability due to software implementation costs and a dependence on government clinic budgets. Simultaneously, the business is implementing sustainable drug procurement methods to reduce waste, with the metric standing at 0.00. This price chart clearly demonstrates the asset's dynamics. Geopolitically, the firm is minimizing risks by focusing on the protected markets of the US and allied states.

WORX - Utang jangka dawa marang ekuitas SCWorx Corporation ing rentang 04.07.2022 - 28.10.2026
Barang utama SCWorx Corp

The stability of the SCWorx Corp. (WORX) B2B model and its strategic focus on healthcare IT experts establish a resilient operational foundation. By analyzing the long-term debt-to-equity trend, an investor evaluates the ratio of liabilities exceeding one year against net assets. This metric filters out short-term volatility to reveal the actual debt load on equity. While a decreasing ratio minimizes bankruptcy risk, it may also indicate an inefficient use of leverage, which ultimately determines the business's financial autonomy.

Perusahaan pesaing

Rasio tanggungan utang jangka dawa marang modal Veeva Systems (VEEV)|Rasio utang jangka dawa marang ekuitas Doximity Corp|Rasio silihan jangka dawa marang modal HealthEquity Building HQY|Rasio utang jangka dawa marang ekuitas Waystar Holding Corp.|corvel.com - Koefisien utang jangka dawa marang modal|PRVA: Utang jangka dawa marang ekuitas|HURN - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal CERT|Omnicell Health (OMCL) - Kewajiban jangka dawa marang modal|Utang jangka dawa marang modal GoodRx Holdings, Inc. (GDRX)|Rasio utang jangka dawa marang modal SDGR|PHR (Phreesia) - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Omada Health, Inc. (OMDA)|Evolent - Utang jangka dawa marang modal|HSTM - Rasio utang jangka dawa marang ekuitas|DH: Rasio utang jangka dawa marang ekuitas|CCSI: Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas AGL|ABSI (Absci Corp) - Kewajiban jangka dawa marang modal|SY - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal nrchealth.com (NRC)|Rasio utang jangka dawa marang ekuitas Spok Holdings, Inc. SPOK|Rasio utang jangka dawa marang modal optimizerx.com OPRX|Rasio utang jangka dawa marang ekuitas TruBridge|Koefisien utang jangka dawa marang modal Simulations Plus Inc SLP|SOPH: Utang jangka dawa marang modal|HCAT: Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas CCLD|RSSS (researchsolutions.com) - Kewajiban jangka dawa marang modal|DLHC - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal ONMD|SCNX - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas Healthcare Triangle Corporation HCTI|Rasio utang jangka dawa marang ekuitas ISPC|BFRG - Rasio tanggungan utang jangka dawa marang modal|MSPR: Rasio utang jangka dawa marang ekuitas|ICCT: Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas MEDS|ORGS (Orgenesis Corporation) - Kewajiban jangka dawa marang modal|RCM - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal sharecare.com (SHCR)|Rasio utang jangka dawa marang ekuitas Streamline Health STRM|Rasio utang jangka dawa marang modal Syra Health Corp (SYRA)|Utang jangka dawa marang modal AMEH|MODN - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas NextGen Healthcare NXGN